Vitafoods Insights looks back at some of the nutraceutical industry’s highlights of 2024. From pets to menopause to probiotics for neurodiversity, we’ve rounded up our most-read stories of the year.
Natural pet supplements are gaining momentum as owners increasingly look for ways to enhance their animal companions’ health and wellbeing, mirroring trends in human nutrition.
Blackcurrant supplementation may help to mitigate bone loss in post-menopausal women, according to US researchers.
A new analysis of data has revealed that daily supplementation with antioxidant vitamins and minerals may slow progression of late-stage ‘dry’ age-related macular degeneration (AMD), potentially helping people preserve their vision.
Drinking more than 400 mg of caffeine daily could increase the risk of cardiovascular disease among otherwise healthy individuals, warn Indian researchers.
Sun Genomics’ precision probiotics brand, Floré, has launched a line of supplements that could benefit neurodiverse individuals with conditions such as autism spectrum disorder (ASD).
Chrononutrition, an emerging field of science that places emphasis on meal timing, is gaining attention among consumers looking to lose weight and optimise their health.
Cognitive health is a bright spot for the nutraceuticals sector right now. We explore its prospects as sustainability-led regulation steps up a gear and consumer focus shifts towards the environmental and ethical impacts of ingredients.
Consumers are increasingly seeking out products that address cognitive and emotional health. We take a deep dive into the key trends driving this demand, as stress relief, sleep, and brain function become central to overall wellness.
Ensuring products are backed by robust research is crucial for nutraceutical brands to gain consumer trust – but equally important is how they communicate those credentials, says Professor Mohammed Gulrez Zariwala, director of the University of Westminster’s Centre for Nutraceuticals.
Two rulings in the UK regarding advertising cannabidiol (CBD) brands to children have underlined the challenges and risks that small businesses face in navigating fast-evolving regulatory environments.
